Latest News
History of MI May Be Associated With Greater Risk for Sudden Death in HFpEF
National Lipid Association Statement on Genetic Testing in Dyslipidemia
Telehealth Services Not Offered at Many US Hospitals
Globally, Women Less Likely to Develop Heart Disease Than Men
Greater Measures of HDL Functionality Associated With Reduced CVD Risk
Genetic Susceptibility Underlies Greater Risk for Arrhythmia, SCD in Blacks With COVID-19
Brilinta Approved to Reduce Risk of First MI, Stroke in High-Risk CAD Patients
Oral Selexipag Safe, Effective in Children With Pulmonary Arterial Hypertension
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
AMI Management in the COVID-19 Era: Consensus Statement
Addition of Evolocumab to Maximally Tolerated Statin Therapy Not Found to Affect Cognition
Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure
Renal Function Improves Mortality Risk Assessment in Pulmonary Arterial Hypertension
Palliative Care Linked to Fewer Readmissions for Heart Failure
Latest Features
Seven Things to Consider When Transitioning to Telemedicine During COVID-19
The use of telemedicine has been surging since the onset of coronavirus disease 2019 (COVID-19), with millions of Americans now using this medium for connecting with their clinicians.
The Seasonality Issue: Wishful Thinking for SARS-CoV-2?
It is certainly too early to know if there will be any seasonal variation to SARS-CoV-2 infection, and there is no reason to specifically compare this virus with the seasonal behavior of influenza virus or to other seasonal respiratory viruses.
Kawasaki Disease Symptoms and COVID-19 in Pediatric Populations: What’s the Link?
Recent reports have indicated an association between a Kawasaki-like disease and COVID-19 in pediatric populations. Mary Beth Son, MD, of the Boston Children’s Hospital weighs in.
-
Loading...
-
Loading...
